P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
about
Tamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsTargeting multidrug resistance in cancerABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast.Gaucher disease: unmet treatment needs.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Transcriptional network governing the angiogenic switch in human pancreatic cancerTherapeutic applications of bioactive sphingolipids in hematological malignancies.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.The role of sphingolipids in drug metabolism and transport.Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.The fungus Ustilago maydis and humans share disease-related proteins that are not found in Saccharomyces cerevisiae.P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.Multiple Roles of Glycans in Hematological Malignancies
P2860
Q28084270-4E245C27-C42E-4E15-8C88-F14BAE6EDC8AQ29616803-DB7A2E79-644E-4012-81B1-B30E80962634Q33228327-8B26F7DA-8AFD-4DD1-B656-1D964CA46716Q33378952-C6383103-604C-43A8-B1FD-32737739BC61Q33763765-24C099CF-A0A1-4EE8-BF0C-0872645D7398Q35911038-4454B3EF-773F-4856-9DA9-BDE07E4D0BB6Q37760875-EED8A6AC-B139-4EA5-83AF-64EE4FADE54EQ38052818-E4A07831-5D28-4315-99E4-44006C934BDAQ38071694-A7147243-ACF1-427C-B00C-F165713C3AC1Q38495744-5A9B177F-B608-4CDC-9215-FB088ADD6BA1Q40394455-F0CAD3E5-6430-4D49-ACF2-1B9E31D3E9B6Q41838245-2BFAAC3D-6CE3-4C89-9DD2-AC85BB9A714BQ47873232-8BEC6D01-71C3-4F2A-9D7B-19119DD29D21Q58761454-558FFF28-C16D-4ACA-841B-24FC8EF004FD
P2860
P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@ast
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@en
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@nl
type
label
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@ast
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@en
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@nl
prefLabel
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@ast
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@en
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@nl
P2093
P1476
P-glycoprotein is implicated i ...... osylceramide synthase pathway.
@en
P2093
Julie Turzanski
Martin Grundy
Monica Pallis
Nigel Russell
Shilli Shang
P356
10.1016/J.EXPHEM.2004.10.005
P577
2005-01-01T00:00:00Z